The FDA’s REMS program has been found to have unintentionally created barriers to accessing clozapine, a crucial antipsychotic drug for treatment-resistant schizophrenia, leading to tragic stories of relapses and suicide attempts.
Is the FDA contributing to the homelessness crisis?
0
Previous ArticleVice-President of Heydar Aliyev Foundation Leyla Aliyeva attends “Seaspiracy” documentary screening (PHOTO)
Next Article How America’s tech right came to power